| 06/02/2026 2:31 PM | Karsanbhai Surendralal Lanca (1754881) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:26 PM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:09 PM | LAVIZZO-MOUREY RISA J (1034465) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:11 PM | Mayo Stephen (1849061) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:14 PM | Merck & Co., Inc. (310158) Issuer Rothman Paul (1601332) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:17 PM | Merck & Co., Inc. (310158) Issuer RUSSO PATRICIA F (1023219) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:19 PM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:21 PM | Merck & Co., Inc. (310158) Issuer THULIN INGE G (1263739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 12:57 PM | BAKER DOUGLAS M JR (1198753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:03 PM | Craig Pamela J. (1232910) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:05 PM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MRK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Merck & Co., Inc. and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/29/2026 12:24 PM | Merck & Co., Inc. (310158) Filer | Form SD Specialized Disclosure Report | |
| 05/22/2026 3:21 PM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 7:14 AM | Merck & Co., Inc. (310158) Filer | Form 424B5 | |
| 05/13/2026 3:06 PM | Merck & Co., Inc. (310158) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/07/2026 11:10 AM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 11:14 AM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 11:18 AM | Merck & Co., Inc. (310158) Issuer Zachary Jennifer (1737231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:52 AM | Davis Robert M (1363076) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:56 AM | DeLuca Richard R. (1421339) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 11:03 AM | Larson Betty D (1617903) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 11:07 AM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:39 AM | Merck & Co., Inc. (310158) Issuer Smart Dalton E. III (2003375) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:42 AM | Merck & Co., Inc. (310158) Issuer Oosthuizen Johannes Jacobus (1916310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:45 AM | Maraldo David R. (2126478) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:48 AM | Foard Brian (2119564) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:36 AM | Guindo Chirfi (1722753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 12:47 PM | Maraldo David R. (2126478) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 12:51 PM | Merck & Co., Inc. (310158) Issuer Smart Dalton E. III (2003375) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 12:08 PM | Maraldo David R. (2126478) Reporting Merck & Co., Inc. (310158) Issuer | Form 3/A | |
| 05/05/2026 7:52 AM | Merck & Co., Inc. (310158) Filed by Terns Pharmaceuticals, Inc. (1831363) Subject | Form SC TO-T/A | |
| 05/04/2026 5:28 PM | Maraldo David R. (2126478) Reporting Merck & Co., Inc. (310158) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/01/2026 5:54 PM | Guindo Chirfi (1722753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 5:32 PM | Chattopadhyay Sanat (1670690) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 5:20 PM | DeLuca Richard R. (1421339) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:55 PM | Merck & Co., Inc. (310158) Issuer Smart Dalton E. III (2003375) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:56 PM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:38 PM | Davis Robert M (1363076) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:39 PM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:42 PM | Larson Betty D (1617903) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:43 PM | Merck & Co., Inc. (310158) Issuer Zachary Jennifer (1737231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening.
The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today |
| 05/01/2026 4:45 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:34 PM | Merck & Co., Inc. (310158) Issuer Oosthuizen Johannes Jacobus (1916310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 10:44 AM | Merck & Co., Inc. (310158) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/30/2026 5:53 AM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/24/2026 6:30 AM | Merck & Co., Inc. (310158) Filed by Terns Pharmaceuticals, Inc. (1831363) Subject | Form SC TO-T/A | |
| 04/08/2026 3:25 PM | Merck & Co., Inc. (310158) Filer | Form DEF 14A | |
| 04/08/2026 3:28 PM | Merck & Co., Inc. (310158) Filer | Form DEFA14A | |
| 04/07/2026 6:00 AM | Merck & Co., Inc. (310158) Filed by Terns Pharmaceuticals, Inc. (1831363) Subject | Form SC TO-T | |
| 04/01/2026 12:42 PM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 12:44 PM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 12:47 PM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 9:31 AM | Merck & Co., Inc. (310158) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/12/2026 12:52 PM | Foard Brian (2119564) Reporting Merck & Co., Inc. (310158) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/10/2026 3:38 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/06/2026 3:10 PM | Guindo Chirfi (1722753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:12 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:13 PM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:15 PM | Merck & Co., Inc. (310158) Issuer Oosthuizen Johannes Jacobus (1916310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:38 PM | Merck & Co., Inc. (310158) Subject Smart Dalton E. III (2003375) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/04/2026 3:26 PM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/04/2026 3:27 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/04/2026 3:29 PM | Davis Robert M (1363076) Reporting Merck & Co., Inc. (310158) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/03/2026 5:38 AM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/28/2026 3:09 PM | Li Dean Y (1837016) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:10 PM | Litchfield Caroline (1854928) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:12 PM | Merck & Co., Inc. (310158) Issuer Oosthuizen Johannes Jacobus (1916310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:18 PM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:19 PM | Merck & Co., Inc. (310158) Issuer Zachary Jennifer (1737231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/07/2026 7:55 AM | Cidara Therapeutics, Inc. (1610618) Subject Merck & Co., Inc. (310158) Filed by | Form SC TO-T/A | |
| 01/05/2026 11:20 AM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 11:22 AM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 11:16 AM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 3:06 PM | Cidara Therapeutics, Inc. (1610618) Subject Merck & Co., Inc. (310158) Filed by | Form SC TO-T/A | |
| 12/17/2025 4:15 PM | Cidara Therapeutics, Inc. (1610618) Subject Merck & Co., Inc. (310158) Filed by | Form SC TO-T/A | |
| 12/05/2025 4:08 PM | Cidara Therapeutics, Inc. (1610618) Subject Merck & Co., Inc. (310158) Filed by | Form SC TO-T | |
| 12/04/2025 3:36 PM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/03/2025 3:22 PM | Merck & Co., Inc. (310158) Filer | Form 424B5 | |
| 12/01/2025 7:19 PM | Merck & Co., Inc. (310158) Subject | Form FWP | |
| 12/01/2025 7:13 AM | Merck & Co., Inc. (310158) Filer | Form 424B5 | |
| 11/04/2025 3:02 PM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/30/2025 5:40 AM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/02/2025 8:28 AM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 8:29 AM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 8:31 AM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2025 3:33 PM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/02/2025 7:15 AM | Merck & Co., Inc. (310158) Filer | Form 424B5 | |
| 08/13/2025 4:05 PM | Merck & Co., Inc. (310158) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 08/05/2025 7:43 AM | Guindo Chirfi (1722753) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:46 AM | Merck & Co., Inc. (310158) Issuer Williams David Michael (1820958) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2025 5:42 AM | Merck & Co., Inc. (310158) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Buy this stock today (Ad) Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7.
One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. Get the name, ticker, and full Hotlist before markets open |
| 07/02/2025 11:04 AM | Coe Mary Ellen (1691304) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2025 11:06 AM | GLOCER THOMAS H (1140799) Reporting Merck & Co., Inc. (310158) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2025 11:08 AM | Merck & Co., Inc. (310158) Issuer Seidman Christine E (1805745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 1:12 PM | Merck & Co., Inc. (310158) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/27/2025 1:16 PM | Merck & Co., Inc. (310158) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/27/2025 1:08 PM | Merck & Co., Inc. (310158) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |